JP Nadda meets former President Ram Nath Kovind
Jul 17, 2024
New Delhi [India], July 17 : Bharatiya Janata Party (BJP) National President JP Nadda met former President Ram Nath Kovind on Wednesday.
The Union Health Minister also reviewed the regulation of drugs, cosmetics and medical devices, earlier in the day and said that India needs to have a world-class regulatory framework to match the country's global reputation as 'Pharmacy of the World'.
"For India to become the global leader in drug regulation to match our global reputation of 'Pharmacy of the World', we need to have a world-class regulatory framework matching our scale of operations and international expectations," Nadda said.
Union Health Secretary Apurva Chandra, drugs-controller-general-of-india" Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi, and senior officers of the Central Drugs Standard Control Organisation (CDSCO) and Union Health Ministry were present at the high-level review meeting.
Highlighting the global position of India as the leading producer and exporter of drugs, Nadda stressed the need for CDSCO to draw a roadmap with timelines for achieving global standards in its mandated activities.
He stated that the upscaling needs to be system-based, focusing on the highest standards of uniformity, technical upgrades, and a futuristic approach. For the export of drugs and pharmaceuticals, the system should be designed for proper intervention to maintain the quality of drugs being exported, he emphasized.
Nadda underscored the importance of transparency in the workings of CDSCO. He stated, "In order to achieve global standards, our focus needs to be on the transparency of procedures at CDCSO and within the drug and medical device industry."
Both the Drugs Regulatory body and the industry should work on the highest principles of transparency to ensure that the products manufactured and sold by India meet the highest indices of global quality standards, he said.
The Union Health Minister stated that it is important for CDSCO to be in continuous dialogue with the drugs and medical devices industry to understand their issues and support them to fulfill the quality expectations and standards of CDSCO. "Our focus should be on developing mechanisms that ensure easy of doing business for the drugs industry within the regulatory requirements. For this, CDSCO needs to be a user-friendly organization with state-of-the-art facilities matching global standards", he stated.
